L. Lahousse (Ghent, Belgium), H. Kankaanranta (Seinäjoki, Finland)
“Smart” inhalers: is there a role in the management of severe asthma?
Y. See (Hull, United Kingdom), E. Chow (Hull, United Kingdom), M. Crooks (Hull, United Kingdom), M. Robinson (Hull, United Kingdom), K. Watkins (Hull, United Kingdom), F. Turner (Hull, United Kingdom), J. Thompson (Hull, United Kingdom), S. Faruqi (Hull, United Kingdom)
|   |
Utility of “smart” inhaler and suppression of fractional exhaled nitric oxide (FeNO): does it make a difference to patient outcomes?
Y. See (Hull, United Kingdom), E. Chow (Hull, United Kingdom), M. Crooks (Hull, United Kingdom), M. Robinson (Hull, United Kingdom), K. Watkins (Hull, United Kingdom), F. Turner (Hull, United Kingdom), J. Thompson (Hull, United Kingdom), S. Faruqi (Hull, United Kingdom), E. Chow (Hull, United Kingdom)
| |
Dry powder inhaler (DPI) resistance: human behaviour and psychology of patient inspiratory effort
M. Chakma (London , United Kingdom), S. Meah (London , United Kingdom), M. Biddiscombe (London , United Kingdom), D. Murnane (Hatfield, United Kingdom), O. Usmani (London , United Kingdom)
| |
Dry Powder Inhalers (DPIs) vs Metered Dose Inhaler (MDI) with valved spacer: Using Functional Respiratory Imaging (FRI) to assess modelled lung deposition in a COPD patient
J. Suggett (London (ON), Canada), V. Kushnarev (London (ON), Canada), H. Sadafi (Kontich, Belgium)
| |
Cardiovascular system side-effects of salbutamol: A systematic review and meta-analysis
L. Ma (Urumqi, China), L. Jia (Urumqi, China), C. Zhi (Shenzhen, China), H. Li (Shenzhen, China), X. Li (Shenzhen, China), L. Bai (Urumqi, China)
| |
Safety profile of triple ICS/LABA/LAMA FDC in the treatment of asthma: a meta-analysis
L. Calzetta (Parma, Italy), F. Cavalli (Rome, Italy), A. Chetta (Parma, Italy), M. Cazzola (Rome, Italy), P. Rogliani (Rome, Italy)
| |
Association of Short-Acting-ß-2 Agonist (SABA) Overuse and Risk of COPD among Adult Asthma Patients
M. Asamoah-Boaheng (St John's, Canada), J. Farrell (St John's, Canada), K. Bonsu (St John's, Canada), W. Midodzi (St John's, Canada)
| |
Improvement of asthma control after 3 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
T. Greulich (Marburg, Germany), B. Akyildiz (Hamburg, Germany), R. Slawinska (Hamburg, Germany), A. Wendt (Hamburg, Germany), V. Bogoevska (Hamburg, Germany), C. Gessner (Leipzig, Germany)
| |
Improvement of treatment adherence after 3 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
C. Gessner (Leipzig, Germany), B. Akyildiz (Hamburg, Germany), V. Grickschat (Hamburg, Germany), T. Borucki (Hamburg, Germany), F. Trinkmann (Heidelberg, Germany)
| |
Dose delivery characteristics and lung deposition of indacaterol/glycopyrronium/mometasone furoate (IND/GLY/MF) and IND/MF via Breezhaler device: An Alberta Idealised Throat (AIT) evaluation
J. Jauernig (Basel, Switzerland), K. Fiebich (Basel, Switzerland), D. Singh (Basel, Switzerland), X. Jaumont (Basel, Switzerland), K. Mezzi (Basel, Switzerland), X. Jaumont (La Madeleine, France)
| |
Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease and Risk of Acquiring Streptococcus Pneumoniae Infection. A Multiregional Epidemiological study
C. Kjer Heerfordt (Hellerup, Denmark), J. Eklöf (Hellerup, Denmark), P. Sivapalan (Hellerup, Denmark), T. Ingebrigtsen (Hellerup, Denmark), T. Biering-Sørensen (Copenhagen, Denmark), Z. Barrella Harboe (Hillerød, Denmark), J. Petersen (Naestved and Roskilde , Denmark), C. Andersen (Hvidovre, Denmark), J. Boel (Herlev, Denmark), A. Bock (Aarhus, Denmark), A. Mathioudakis (Manchester, United Kingdom), J. Hurst (London, United Kingdom), S. Kolekar (Roskilde, Denmark), S. Johansson (Odense, Denmark), J. Bangsborg (Herlev, Denmark), J. Jarløv (Herlev, Denmark), R. Dessau (Slagelse, Denmark), C. Laursen (Odense, Denmark), M. Perch (Copenhagen, Denmark), J. Jensen (Hellerup and Copenhagen, Denmark)
| |
Disease burden and treatment patterns among patients with asthma on GINA 4/5 therapies in China
V. Benson (Brentford, Middlesex, United Kingdom), G. Liu (Shanghai, China), A. Haq (Bollington, Cheshire, United Kingdom), M. Small (Bollington, Cheshire, United Kingdom), J. Siddall (Bollington, Cheshire, United Kingdom), R. Alfonso-Cristancho (Collegeville, PA, United States), A. Richards (Brentford, Middlesex, United Kingdom)
| |
Disease burden and treatment patterns among patients with asthma in China
V. Benson (Brentford, United Kingdom), J. Siddall (Bollington, United Kingdom), G. Liu (Shanghai, China), A. Richards (Brentford, United Kingdom), A. Haq (Bollington, United Kingdom), R. Alfonso-Cristancho (Collegeville, United States), M. Small (Bollington, United Kingdom)
| |
A randomised controlled trial of the effects of a total diet replacement programme in uncontrolled asthma associated with obesity
V. Sharma (Glasgow, United Kingdom), H. Ricketts (Glasgow, United Kingdom), L. Mccombie (Glasgow, United Kingdom), N. Brosnahan (Glasgow, United Kingdom), L. Crawford (Glasgow, United Kingdom), L. Slaughter (Glasgow, United Kingdom), A. Goodfellow (Glasgow, United Kingdom), F. Steffensen (Glasgow, United Kingdom), R. Chaudri (Glasgow, United Kingdom), M. Lean (Glasgow, United Kingdom), D. Cowan (Glasgow, United Kingdom)
| |
Two-month treatment with Zataria multiflora affected inflammatory cytokines, pulmonary function testes and respiratory symptoms in patients with chronic obstructive pulmonary disease (COPD)
M. Boskabady (Mashhad, Islamic Republic of Iran), V. Ghorani (Mashhad, Islamic Republic of Iran), M. Khazdair (Mashhad, Islamic Republic of Iran), M. Mirsadraee (Mashhad, Islamic Republic of Iran), O. Rajabi (Mashhad, Islamic Republic of Iran)
| |
The availability, cost and affordability of essential medicines for asthma and COPD in low- and middle-income countries: A systematic review
M. Stolbrink (Liverpool, United Kingdom), H. Thomson (London, United Kingdom), R. Hadfield (Sydney, Australia), O. Ozoh (Lagos, Nigeria), R. Nantanda (Kampala, Uganda), S. Jayasooria (Sheffield, United Kingdom), B. Allwood (Cape Town, South Africa), D. Halpin (Exeter, United Kingdom), S. Salvi (Pune, India), M. Montes De Oca (Caracas, Venezuela), K. Mortimer* (Liverpool, United Kingdom), S. Rylance* (Geneva, Switzerland)
| |
Characterization of a Colombian cohort of high-risk phenotypes of COPD according to GesEPOC 2021
C. Celis Preciado (Bogotá (Cundinamarca), Colombia), O. García Morales (Bogotá (Cundinamarca), Colombia), A. Cañas Arboleda (Bogotá (Cundinamarca), Colombia), F. Rodriguez Torres (Bogotá (Cundinamarca), Colombia), J. Galindo Pedraza (Bogotá (Cundinamarca), Colombia), J. Alzate Granados (Bogotá (Cundinamarca), Colombia)
| |
Physical activity, sedentary behaviour and sleep of Sri Lankan adults living with COPD: cross-sectional study
A. Jayamaha (Colombo, Sri Lanka), C. Perera (Colombo, Sri Lanka), I. Pina (Leicester, United Kingdom), T. Amarasekara (Nugegoda, Sri Lanka), A. Seneviratne (Colombo, Sri Lanka), R. Karunatillake (Colombo, Sri Lanka), A. Fernando (Colombo, Sri Lanka), A. Barton (Leicester, United Kingdom), M. Steiner (Leicester, United Kingdom), S. Wimalasekera (Colombo, Sri Lanka), S. Singh (Leicester, United Kingdom), M. Orme (Leicester, United Kingdom)
| |
EDAC PREVALENCE AND ASSOCIATED FACTORS IN PATIENTS WITH SEVERE BRONCHIAL ASTHMA
I. Alfaya Fiaño (badalona, Spain), A. Solis Solis (badalona, Spain), F. Andreo Garcia (badalona, Spain), P. Serra Mitja (badalona, Spain), . Crespo Lessmann (barcelona, Spain), A. Torrego Fernández (barcelona, Spain), . Ramos Barbón (barcelona, Spain), . Zapata Comas (badalona, Spain), I. Garcia Olivé (badalona, Spain), V. Plaza Moral (barcelona, Spain), A. Rosell Gratacós (badalona, Spain), J. Abad Capa (badalona, Spain), C. Martínez Rivera (badalona, Spain)
| |
Asthma patients discharged from the emergency department in Ireland: an unmet need?
C. Forward (Galway, Ireland), R. O'Loghlin (Galway, Ireland), H. Mulryan (Galway, Ireland), D. Langan (Galway, Ireland), M. Harrison (Galway, Ireland), R. Rutherford (Galway, Ireland), R. Cusack (Galway, Ireland)
| |